Business description: AS Olainfarm

Number of employees: 2,191
Sales by Activity: AS Olainfarm
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) |
|---|---|---|
Manufacturing of Medicines | 86.84M | 75.65M |
Retail Sale | 25.67M | 26.82M |
Wholesale | 17.55M | 17.27M |
Other Segments | 12.67M | 10.46M |
Compression Products | 12.45M | 8.41M |
Unallocated and Eliminated | -17.97M | -16.45M |
Geographical breakdown of sales: AS Olainfarm
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) |
|---|---|---|
Latvia | 38.8M | 39.18M |
Russia | 44.08M | 28.02M |
Belarus | 15.16M | 15.26M |
Central Asia | 11.15M | 11.56M |
Ukraine | 10.71M | 11.46M |
EU Countries | 10.62M | 9.5M |
Other Countries | 4.6M | 4.75M |
Caucasus Countries | 2.1M | 2.44M |
Executive Committee: AS Olainfarm
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 | |
| Chief Tech/Sci/R&D Officer | 47 | 2017-06-11 | |
| Chief Tech/Sci/R&D Officer | - | 2005-12-31 |
Composition of the Board of Directors: AS Olainfarm
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2021-06-18 | |
Janis Buks
CHM | Chairman | - | 2022-08-31 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
Vadims Telica
BRD | Director/Board Member | 63 | - |
| Director/Board Member | - | - |
Company details: AS Olainfarm

Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.18% | -3.43% | +36.07% | +115.04% | 1,019B | ||
| -0.86% | -5.60% | +35.72% | +64.63% | 617B | ||
| -0.65% | -0.58% | +12.36% | +77.95% | 464B | ||
| -2.26% | -3.01% | +61.79% | +41.24% | 356B | ||
| +0.61% | -2.08% | +20.67% | +41.06% | 333B | ||
| +0.26% | -3.36% | +10.89% | +34.50% | 267B | ||
| -0.44% | -4.92% | -6.66% | +8.95% | 244B | ||
| -0.56% | -2.79% | +35.30% | +51.84% | 218B | ||
| -0.56% | -4.10% | +28.44% | +93.66% | 179B | ||
| Average | -0.42% | -3.54% | +26.06% | +58.76% | 410.8B | |
| Weighted average by Cap. | -0.19% | -3.54% | +29.08% | +70.63% |

















